Skip to main content
Top
Published in: Diabetologia 11/2019

01-11-2019 | Obesity | Article

Persistent effects of in utero overnutrition on offspring adiposity: the Exploring Perinatal Outcomes among Children (EPOCH) study

Authors: Christine W. Hockett, Kylie K. Harrall, Brianna F. Moore, Anne P. Starling, Anna Bellatorre, Katherine A. Sauder, Wei Perng, Ann Scherzinger, Kavita Garg, Brandy M. Ringham, Deborah H. Glueck, Dana Dabelea

Published in: Diabetologia | Issue 11/2019

Login to get access

Abstract

Aims/hypothesis

We previously showed that intrauterine exposure to gestational diabetes mellitus (GDM) increases selected markers of adiposity in pre-pubertal adolescents. In the present study, we examined these associations in adolescence, and explored whether they are strengthened as the participants transition through puberty.

Methods

Data from 597 individuals (505 unexposed, 92 exposed) participating in the longitudinal Exploring Perinatal Outcomes among Children (EPOCH) study in Colorado were collected at two research visits when the participants were, on average, 10.4 and 16.7 years old. Adiposity measures included BMI, waist/height ratio, and visceral and subcutaneous adipose tissue (as determined by MRI). Separate general linear mixed models were used to assess the longitudinal relationships between exposure to maternal GDM and each adiposity outcome. We tested whether the effect changed over time by including an interaction term between exposure and age in our models, and whether the associations were explained by postnatal behaviours.

Results

Compared with unexposed participants, those exposed to maternal GDM had higher BMI (β = 1.28; 95% CI 0.35, 2.21; p < 0.007), waist/height ratio (β = 0.03; 95% CI 0.01, 0.04; p = 0.0004), visceral adipose tissue (β = 4.81; 95% CI 1.08, 8.54; p = 0.01) and subcutaneous adipose tissue (β = 35.15; 95% CI 12.43, 57.87; p < 0.003). The magnitude of these differences did not change over time and the associations did not appear to be explained by postnatal behaviours.

Conclusions/interpretation

Our data provide further evidence that intrauterine exposure to maternal GDM is associated with increased offspring adiposity, an effect that appears early in life and tracks throughout adolescence. Efforts to prevent childhood obesity following intrauterine exposure to maternal GDM should target the prenatal or early life periods.
Appendix
Available only for authorised users
Literature
16.
24.
go back to reference Sperling MA (2014) Pediatric endocrinology. Elsevier Health Sciences, Philadelphia Sperling MA (2014) Pediatric endocrinology. Elsevier Health Sciences, Philadelphia
31.
go back to reference Sauder K, Bekelman T, Harrall K, Glueck D, Dabelea D (2019) Gestational diabetes exposure and adiposity outcomes in childhood and adolescence: an analysis of effect modification by breastfeeding, diet quality, and physical activity in the EPOCH study. Pediatr Obes. https://doi.org/10.1111/ijpo.12562 Sauder K, Bekelman T, Harrall K, Glueck D, Dabelea D (2019) Gestational diabetes exposure and adiposity outcomes in childhood and adolescence: an analysis of effect modification by breastfeeding, diet quality, and physical activity in the EPOCH study. Pediatr Obes. https://​doi.​org/​10.​1111/​ijpo.​12562
Metadata
Title
Persistent effects of in utero overnutrition on offspring adiposity: the Exploring Perinatal Outcomes among Children (EPOCH) study
Authors
Christine W. Hockett
Kylie K. Harrall
Brianna F. Moore
Anne P. Starling
Anna Bellatorre
Katherine A. Sauder
Wei Perng
Ann Scherzinger
Kavita Garg
Brandy M. Ringham
Deborah H. Glueck
Dana Dabelea
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Keywords
Obesity
Obesity
Published in
Diabetologia / Issue 11/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-04981-z

Other articles of this Issue 11/2019

Diabetologia 11/2019 Go to the issue

Up Front

Up front

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.